US Patent No. 8,911,940

Methods of assessing a risk of cancer progression
Dec 19, 2014

The Translational Genomics Research Institute and Scottsdale Healthcare Corporation have been awarded US Patent No. 8,911,940, "Methods of assessing a risk of cancer progression."

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

Sponsored by

This webinar will present the results of an evaluation of a web-based variant interpretation software system for clinical next-generation sequencing.